Position in LGND
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$186,183,331
+$74,592,159 QoQ
Shares Held
589,020
+5.4% QoQ
Ownership
2.95%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. LGND ranks #29 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in LGND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $186,183,331 | 589,020 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $111,591,172 | 558,934 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $93,322,871 | 493,589 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $83,997,839 | 474,189 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $55,564,282 | 488,778 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $48,832,483 | 464,452 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $46,978,953 | 438,441 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $42,865,544 | 428,270 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $34,190,600 | 405,775 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $27,848,907 | 380,970 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $26,483,607 | 370,815 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $21,129,050 | 352,621 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $24,630,297 | 341,613 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $23,303,734 | 316,799 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,084,756 | 300,670 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $24,981,358 | 290,110 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $25,938,465 | 290,725 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $33,814,169 | 300,597 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $43,969,032 | 284,663 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $38,454,392 | 276,015 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $36,413,096 | 277,560 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $40,075,432 | 262,876 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $23,252,096 | 233,807 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $22,098,605 | 231,836 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $26,942,755 | 240,883 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $18,894,311 | 259,823 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||